CCND1 and mantle cell lymphoma: Notably, pharmacological approaches such as arsenic trioxide, a front-line treatment for acute promyelocytic leukemia (Schick et al. 2022), increases sumoylation-mediated degradation of cyclin D1 by inhibiting SENPs, resulting in apoptosis of MCL cells (Lu et al. 2024).